论文部分内容阅读
目的:探讨红霉素在新生儿胃肠道功能紊乱治疗中的临床效果。方法:选取2013年6月~2015年9月某院收治的胃肠道功能紊乱新生儿78例作为调查对象,通过回顾分析,将其随机分为对照组(39例)和研究组(39例),对照组主要采用常规治疗,研究组主要采用红霉素治疗,对两组患儿的临床效果、肠外营养时间、肝功能损害、肠内营养时间、住院时间等进行比较。结果:对照组总有效率87.64%,研究组总有效率98.34%,两组疗效对比,差异显著(P<0.05),有统计学意义。其中研究组的肠外营养时间、肝功能损害、肠内营养时间、住院时间等都要优于对照组,两组疗效对比,差异显著(P<0.05),有统计学意义。结论:对胃肠道功能紊乱新生儿采用红霉素治疗,在临床中取得了显著的疗效,值得推广使用。
Objective: To investigate the clinical effect of erythromycin in the treatment of neonatal gastrointestinal disorders. Methods: Seventy-eight neonates with gastrointestinal dysfunction admitted to our hospital from June 2013 to September 2015 were selected as the research objects. By retrospective analysis, they were randomly divided into control group (39 cases) and study group (39 cases ). The control group was mainly treated with conventional therapy. The study group mainly used erythromycin to treat the children. The clinical effects, parenteral nutrition time, liver function impairment, enteral nutrition time and hospital stay were compared between the two groups. Results: The total effective rate of the control group was 87.64%, and the total effective rate of the study group was 98.34%. There was significant difference between the two groups (P <0.05). The study group’s parenteral nutrition time, liver damage, enteral nutrition time and hospital stay were all better than the control group. There was significant difference between the two groups (P <0.05). Conclusion: Erythromycin is used to treat neonates with gastrointestinal disorders, which has achieved remarkable clinical efficacy and is worth promoting.